Who-umc.org | | Slzii.com |

Slzii.com

https://who-umc.org

Uppsala Monitoring Centre | UMC

Advancing medicines safety together

Uppsala Monitoring Centre | UMC Who we are About Uppsala Monitoring Centre About the WHO Programme for International Drug Monitoring Careers Trending PV Cycle About the WHO PIDM Opportunities for students What we do Research Signal Work Education & Training Pharmacovigilance communications Publications library IDMP implementation Trending Quick guides for effective communication Signal detection IDMP implementation Our products WHODrug WHODrug portfolio WHODrug Subscription WHODrug News VigiBase Services VigiBase Services VigiBase Custom Searches VigiAccess API PV Solutions PV Products VigiFlow VigiFlow for AEFI VigiMobile VigiLyze PV Product Support WHODrug User Area Service status Trending products WHODrug Koda VigiFlow eReporting for Industry Contact us Contact information Privacy policy Get in touch Product enquiry Help and support Log in Leading the way in medicinal product safety UMC expands the boundaries of pharmacovigilance to enable safer use of medicines and vaccines. Read more Leading the way in medicinal product safety UMC expands the boundaries of pharmacovigilance to enable safer use of medicines and vaccines. Read more Protecting patients from harm We collect and analyse data from most countries around the world to make sure appropriate standards and systems are in place to prevent unnecessary harm to patients. Read more Protecting patients from harm We collect and analyse data from most countries around the world to make sure appropriate standards and systems are in place to prevent unnecessary harm to patients. Read more IDMP – new standards for safety Harmonising medicinal product definitions for safer medicines everywhere. Read more IDMP – new standards for safety Harmonising medicinal product definitions for safer medicines everywhere. Read more Previous Next WHODrug One complete reference guide for precise drug coding, better patient safety and safer medicines WHO Programme for International Drug Monitoring A vital, global collaboration to protect patients from the harm that medicines can cause Signal detection Identifying sources of potential harm to patients is UMC’s highest priority VigiBase The unique global resource at the heart of the drive for safer use of medicines Latest news 2024-09-11 New film tells the story of how Botswana has worked to reduce under-reporting, making full use of the tools provided by UMC 2024-08-26 New podcast on weeding out duplicates to better detect side-effects 2024-07-02 Ensuring trust in AI/ML when used in pharmacovigilance – new podcast out now 2024-06-07 New podcast on preventing and reporting medication errors Working for a better world In our role as a WHO Collaborating Centre, we provide training, guidance and support to members of the WHO Programme for International Drug Monitoring (WHO PIDM). We also manage VigiBase, the WHO global database of adverse event reports for medicines and vaccines – the largest database of its kind in the world. Click on our interactive map for more information on members of the WHO PIDM [{data: [ {"iso-a2":"AD",value:2008,category:"Full Member", links:[{name:"Service of Pharmacy",link:"http://www.salut.ad/"}]}, {"iso-a2":"AE",value:2013,category:"Full Member", links:[{name:"United Arab Emirates, Ministry of Health",link:"http://www.mohap.gov.ae/en/Pages/default.aspx"}]}, {"iso-a2":"AF",value:2016,category:"Full Member", links:[{name:"National Medicine and Healthcare Products Regulatory Authority",link:"https://nmhra.gov.af/"}]}, {"iso-a2":"AG",value:2008,category:"Associate Member", links:[{name:"Mount St. John's Medical Centre",link:"http://www.paho.org"}]}, {"iso-a2":"AI",value:2008,category:"Associate Member", links:[{name:"Princess Alexandra Hospital",link:"http://www.paho.org"}],displayName:"Anguilla"}, {"iso-a2":"AL",value:2020,category:"Full Member", links:[{name:"National Agency for Medicines and Medical Devices",link:"http://www.akbpm.gov.al"}]}, {"iso-a2":"AM",value:2001,category:"Full Member", links:[{name:"Scientific Centre of Drug and Medical Technology Expertise",link:"http://pharm.am/index.php/en/drug-safety-profile "}]}, {"iso-a2":"AO",value:2013,category:"Full Member", links:[{name:"Agência Reguladora de Medicamentos e Tecnologias de Saúde (ARMED)",link:"https://armed.gov.ao/notificacao-de-ram/"}]}, {"iso-a2":"AR",value:1994,category:"Full Member", links:[{name:"Administración Nacional de Medicamentos, Alimentos y Tecnología Médica",link:"https://www.argentina.gob.ar/anmat"}]}, {"iso-a2":"AS",value:1968,category:"Full Member", links:[{name:"US FDA, Center for Biologics Evaluation and Research",link:"http://www.fda.gov/cber"},{name:" US FDA, Center for Drug Evaluation and Research",link:"http://www.fda.gov/cder"}]}, {"iso-a2":"AT",value:1991,category:"Full Member", links:[{name:"Austrian Agency for Health and Food Safety",link:"https://www.basg.gv.at/en/"}]}, {"iso-a2":"AU",value:1968,category:"Full Member", links:[{name:"Therapeutic Goods Administration",link:"http://www.tga.gov.au"}]}, {"iso-a2":"AW",value:1968,category:"Full Member", links:[{name:"Netherlands Pharmacovigilance Centre Lareb",link:"http://www.lareb.nl/?lang=en-GB"}]}, {"iso-a2":"AZ",value:2018,category:"Full Member", links:[{name:"Analytical Expertise Center",link:"http://pharma.az/"}]}, {"iso-a2":"BA",value:2019,category:"Full Member", links:[{name:"Agency for Medicines and Medical Devices of Bosnia and Herze",link:"http://www.almbih.gov.ba/"}]}, {"iso-a2":"BB",value:2008,category:"Full Member", links:[{name:"Barbados Drug Service",link:"http://http://drugservice.gov.bb/"}]}, {"iso-a2":"BD",value:2014,category:"Full Member", links:[{name:"Directorate General of Drug Administration",link:"http://www.dgda.gov.bd/index.php/2013-03-31-04-35-57/adrm-reaction-monitoring"}]}, {"iso-a2":"BE",value:1977,category:"Full Member", links:[{name:"Federal Agency for Medicines and Health Products",link:"https://www.famhp.be/en"}]}, {"iso-a2":"BF",value:2010,category:"Full Member", links:[{name:"Direction Generale de la Pharmacie (DGPML)",link:"http://www.dgpml.sante.gov.bf"}]}, {"iso-a2":"BG",value:1975,category:"Full Member", links:[{name:"Bulgarian Drug Agency",link:"http://www.bda.bg"}]}, {"iso-a2":"BH",value:2002,category:"Associate Member", links:[{name:"Pharmacy and Drug Control",link:"http://www.moh.gov.bh/"}]}, {"iso-a2":"BI",value:2022,category:"Full Member", links:[{name:"Direction de la Pharmacie, du Médicament et des Laboratoires",link:""}]}, {"iso-a2":"BJ",value:2011,category:"Full Member", links:[{name:"Agence Béninoise du Médicament",link:"https://www.abrp.bj/index.php"}]}, {"iso-a2":"BL",value:1986,category:"Full Member", links:[{name:"Agence nationale de sécurité du médicament et des produits de santé (ANSM)",link:"http://ansm.sante.fr"}]}, {"iso-a2":"BM",value:1968,category:"Full Member", links:[{name:"Medicines and Healthcare products Regulatory Agency",link:"http://www.mhra.gov.uk"}]}, {"iso-a2":"BN",value:2005,category:"Full Member", links:[{name:"National Adverse Drug Reaction Monitoring Centre",link:"http://www.moh.gov.bn/SitePages/Pharmacy%20Overview.aspx"}]}, {"iso-a2":"BO",value:2013,category:"Full Member", links:[{name:"Centro Nacional de Farmacovigilancia",link:"http://www.minsalud.gob.bo/"}]}, {"iso-a2":"BQ",value:1968,category:"Full Member", links:[{name:"Netherlands Pharmacovigilance Centre Lareb",link:"http://www.lareb.nl/?lang=en-GB"}]}, {"iso-a2":"BR",value:2001,category:"Full Member", links:[{name:"Agencia Nacional de Vigilanica Sanitaria",link:"http://portal.anvisa.gov.br/farmacovigilancia"},{name:"Universidade de Sao Paulo",link:"Not applicable"}]}, {"iso-a2":"BS",value:2020,category:"Associate Member", links:[{name:"Ministry of Health",link:"https://www.bahamas.gov.bs/"}]}, {"iso-a2":"BT",value:2014,category:"Full Member", links:[{name:"National Pharmacovigilance Centre",link:"http://dra.gov.bt/"}]}, {"iso-a2":"BW",value:2009,category:"Full Member", links:[{name:"Drug Regulatory Unit",link:"http://www.moh.gov.bw/"}]}, {"iso-a2":"BY",value:2006,category:"Full Member", links:[{name:"Center for Examinations and Testing in Health Service",link:"http://rceth.by/ru/Safety"}]}, {"iso-a2":"BZ",value:2020,category:"Associate Member", links:[{name:"Pharmacy Department of the Ministry of Health",link:"https://www.health.gov.bz/services/pharmacy/"}]}, {"iso-a2":"CA",value:1968,category:"Full Member", links:[{name:"Health Canada",link:"http://www.hc-sc.gc.ca"},{name:"Vaccine Preventable Diseases & Vaccine Safety",link:"http://www.phac-aspc.gc.ca"}]}, {"iso-a2":"CC",value:1968,category:"Full Member", links:[{name:"Therapeutic Goods Administration",link:"http://www.tga.gov.au"}]}, {"iso-a2":"CD",value:2010,category:"Full Member", links:[{name:"Centre National de Pharmacovigilance",link:""}]}, {"iso-a2":"CF",value:2022,category:"Full Member", links:[{name:"Ministre de la Santé et de la Population",link:""}]}, {"iso-a2":"CG",value:2021,category:"Full Member", links:[{name:"Ministère de la Santé",link:"https://sante.gouv.cg/"}]}, {"iso-a2":"CH",value:1991,category:"Full Member", links:[{name:"Swissmedic",link:"https://www.swissmedic.ch/swissmedic/de/home.html"}]}, {"iso-a2":"CI",value:2010,category:"Full Member", links:[{name:"Autorité Ivoirienne de Régulation Pharmaceutique (AIRP)",link:"https://www.airp.ci/fr"}]}, {"iso-a2":"CK",value:2020,category:"Associate Member", links:[{name:"",link:""}],displayName:"Cook Islands"}, {"iso-a2":"CL",value:1996,category:"Full Member", links:[{name:"Instituto de Salud Publica de Chile",link:"http://www.ispch.cl/anamed_/farmacovigilancia"}]}, {"iso-a2":"CM",value:2010,category:"Full Member", links:[{name:"Direction de la Pharmacie et du Médicament",link:""}]}, {"iso-a2":"CN",value:1998,category:"Full Member", links:[{name:"China Food and Drug Administration",link:"http://english.nmpa.gov.cn/index.html"}]}, {"iso-a2":"CO",value:2004,category:"Full Member", links:[{name:"Instituto Nacional de Vigilancia de Medicamentos y Alimentos",link:"https://www.invima.gov.co/index.php?option=com_content&view=article&id=764:farmacovigilancia&catid=191:farmacovigilancia&Itemid=323"}]}, {"iso-a2":"CR",value:1991,category:"Full Member", links:[{name:"Centro Nacional de Farmacovigilancia",link:"https://www.ministeriodesalud.go.cr/"}]}, {"iso-a2":"CU",value:1994,category:"Full Member", links:[{name:"Centro para el Control Estatal de Medicamentos, Equipos y Dispositivos Médicos",link:"https://www.cecmed.cu/vigilancia"}]}, {"iso-a2":"CV",value:2012,category:"Full Member", links:[{name:"Centro Nacional de Farmacovigilância (CNF)",link:"https://www.eris.cv/index.php/setor-farmaceutico/farmacovigilancia"}]}, {"iso-a2":"CW",value:1968,category:"Full Member", links:[{name:"Netherlands Pharmacovigilance Centre Lareb",link:"http://www.lareb.nl/?lang=en-GB"}]}, {"iso-a2":"CX",value:1968,category:"Full Member", links:[{name:"Therapeutic Goods Administration",link:"http://www.tga.gov.au"}]}, {"iso-a2":"CY",value:2000,category:"Full Member", links:[{name:"Pharmaceutical Services",link:"https://www.moh.gov.cy/moh/moh.nsf/index_en/index_en?OpenDocument"}]}, {"iso-a2":"CZ",value:1992,category:"Full Member", links:[{name:"State Institute for Drug Control, Czech Republic",link:"http://www.sukl.eu/index.php?lang=2"}]}, {"iso-a2":"DE",value:1968,category:"Full Member", links:[{name:"Federal Institute for Drugs and Medical Devices",link:"http://www.bfarm.de/cln_012/nn_424276/EN"},{name:"Paul Ehrlich Institut",link:"https://www.pei.de/EN/medicine-safety/pharmacovigilance/pharmacovigilance-node.html"}]}, {"iso-a2":"DJ",value:2023,category:"Associate Member", links:[{name:"Ministère de la Santé",link:"https://sante.gouv.dj/"}]}, {"iso-a2":"DK",value:1971,category:"Full Member", links:[{name:"Danish Medicines Agency",link:"https://laegemiddelstyrelsen.dk/en/sideeffects/"}]}, {"iso-a2":"DM",value:2008,category:"Associate Member", links:[{name:"Grand Health Center",link:"http://www.paho.org"}]}, {"iso-a2":"DO",value:2020,category:"Full Member", links:[{name:"Ministry of Public Health",link:"http://iddi.org/es/salud/"}]}, {"iso-a2":"DZ",value:2021,category:"Full Member", links:[{name:"Centre National de Pharmacovigilance et de Materiovigilance",link:"http://www.cnpm.org.dz"}]}, {"iso-a2":"EC",value:2017,category:"Full Member", links:[{name:"Agencia Nacional de Regulación, Control y Vigilancia Sanitaria",link:"http://www.controlsanitario.gob.ec"}]}, {"iso-a2":"EE",value:1998,category:"Full Member", links:[{name:"State Agency of Medicines",link:"http://www.ravimiamet.ee/en"}]}, {"iso-a2":"EG",value:2001,category:"Full Member", links:[{name:"Egyptian Pharmaceutical Vigilance Center",link:"https://www.edaegypt.gov.eg"}]}, {"iso-a2":"ER",value:2012,category:"Full Member", links:[{name:"Eritrean National Pharmacovigilance Centre",link:"http://pveritrea.com/"}]}, {"iso-a2":"ES",value:1984,category:"Full Member", links:[{name:"Spanish Agency for Medicines and Healthcare Products",link:"https://www.aemps.gob.es/vigilancia/medicamentosUsoHumano/home.htm"}]}, {"iso-a2":"ET",value:2008,category:"Full Member", links:[{name:"Food & Drug Authority",link:"http://www.efda.gov.et/"}]}, {"iso-a2":"FI",value:1974,category:"Full Member", links:[{name:"Finnish Medicines Agency",link:"https://fimea.fi/en/pharmaceutical_safety_and_information"}]}, {"iso-a2":"FJ",value:1999,category:"Full Member", links:[{name:"Fiji Pharmaceutical & Biomedical Services Centre",link:"http://www.health.gov.fj"}]}, {"iso-a2":"FK",value:1968,category:"Full Member", links:[{name:"Medicines and Healthcare products Regulatory Agency",link:"http://www.mhra.gov.uk"}]}, {"iso-a2":"FO",value:1971,category:"Full Member", links:[{name:"Danish Medicines Agency",link:"https://laegemiddelstyrelsen.dk/en/sideeffects/"}]}, {"iso-a2":"FR",value:1986,category:"Full Member", links:[{name:"Agence nationale de sécurité du médicament et des produits de santé (ANSM)",link:"http://ansm.sante.fr"}]}, {"iso-a2":"GA",value:2023,category:"Full Member", links:[{name:"Ministère de la Santé et des Affaires sociales",link:"https://www.sante.gouv.ga/contacts"}]}, {"iso-a2":"GB",value:1968,category:"Full Member", links:[{name:"Medicines and Healthcare products Regulatory Agency",link:"http://www.mhra.gov.uk"}]}, {"iso-a2":"GD",value:2008,category:"Associate Member", links:[{name:"Central Medical Stores, Grenada",link:"http://www.paho.org"}]}, {"iso-a2":"GE",value:2018,category:"Full Member", links:[{name:"Lepl Regulatory Agency for Medical and Pharmaceutical Activities",link:"http://moh.gov.ge"}]}, {"iso-a2":"GF",value:1986,category:"Full Member", links:[{name:"Agence nationale de sécurité du médicament et des produits de santé (ANSM)",link:"http://ansm.sante.fr"}]}, {"iso-a2":"GG",value:1968,category:"Full Member", links:[{name:"Medicines and Healthcare products Regulatory Agency",link:"http://www.mhra.gov.uk"}]}, {"iso-a2":"GH",value:2001,category:"Full Member", links:[{name:"Food and Drugs Authority",link:"http://www.fdaghana.gov.gh"}]}, {"iso-a2":"GI",value:1968,category:"Full Member", links:[{name:"Medicines and Healthcare products Regulatory Agency",link:"http://www.mhra.gov.uk"}]}, {"iso-a2":"GL",value:1971,category:"Full Member", links:[{name:"Danish Medicines Agency",link:"https://laegemiddelstyrelsen.dk/en/sideeffects/"}]}, {"iso-a2":"GM",value:2021,category:"Full Member", links:[{name:"Medicines Control Agency",link:"https://www.mca.gm/"}]}, {"iso-a2":"GN",value:2013,category:"Full Member", links:[{name:"Direction Nationale de la Pharmacie et des Laboratoires",link:"https://portail.sante.gov.gn/acteur/dnpm-pharmacie-medicaments/"}]}, {"iso-a2":"GP",value:1986,category:"Full Member", links:[{name:"Agence nationale de sécurité du médicament et des produits de santé (ANSM)",link:"http://ansm.sante.fr"}]}, {"iso-a2":"GR",value:1990,category:"Full Member", links:[{name:"National Organization for Medicines",link:"http://www.eof.gr/web/guest/home"}]}, {"iso-a2":"GT",value:2002,category:"Full Member", links:[{name:"Ministerio de Salud Publica y Asistencia Social",link:"https://medicamentos.mspas.gob.gt/index.php/formularios/farmacovigilancia"}]}, {"iso-a2":"GU",value:1968,category:"Full Member", links:[{name:"US FDA, Center for Biologics Evaluation and Research",link:"http://www.fda.gov/cber"},{name:" US FDA, Center for Drug Evaluation and Research",link:"http://www.fda.gov/cder"}]}, {"iso-a2":"GW",value:2022,category:"Full Member", links:[{name:"Guinée-Bissau Ministério da Saúde",link:""}]}, {"iso-a2":"GY",value:2018,category:"Associate Member", links:[{name:"Ministry of Public Health",link:"http://www.health.gov.gy"}]}, {"iso-a2":"HN",value:2020,category:"Full Member", links:[{name:"Agencia de Regulación Sanitaria",link:"http://www.arsa.gob.hn/"}]}, {"iso-a2":"HR",value:1992,category:"Full Member", links:[{name:"Croatian Agency for Medicinal Products and Devices",link:"http://www.halmed.hr/en/"}]}, {"iso-a2":"HU",value:1990,category:"Full Member", links:[{name:"National Institute of Pharmacy and Nutrion",link:"https://ogyei.gov.hu/medicines"}]}, {"iso-a2":"HT",value:2016,category:"Associate Member", links:[{name:"Ministère de la Santé Publique et de la Population",link:"http://mspp.gouv.ht/"}]}, {"iso-a2":"ID",value:1975,category:"Full Member", links:[{name:"Indonesia National Agency of Drug and Food Control",link:"http://www.pom.go.id/new/index.php/home/en"}]}, {"iso-a2":"IE",value:1968,category:"Full Member", links:[{name:"Health Products Regulatory Authority",link:"http://www.hpra.ie/homepage/medicines"}]}, {"iso-a2":"IL",value:1973,category:"Full Member", links:[{name:"Department of Drug Information and Risk Management",link:"http://www.health.gov.il/English/MinistryUnits/HealthDivision/MedicalTechnologies/Drugs/risk/Pages/default.aspx"}]}, {"iso-a2":"IM",value:1968,category:"Full Member", links:[{name:"Medicines and Healthcare products Regulatory Agency",link:"http://www.mhra.gov.uk"}]}, {"iso-a2":"IN",value:1998,category:"Full Member", links:[{name:"Indian Pharmacopoeia Commission",link:"http://www.ipc.gov.in"}]}, {"iso-a2":"IQ",value:2010,category:"Full Member", links:[{name:"Iraqi Pharmacovigilance Center",link:"http://www.mohiraq.org"}]}, {"iso-a2":"IR",value:1998,category:"Full Member", links:[{name:"Iranian Adverse Drug Reaction Monitoring Centre",link:"http://www.mohme.gov.ir"}]}, {"iso-a2":"IS",value:1990,category:"Full Member", links:[{name:"Icelandic Medicines Agency",link:"http://www.ima.is/Pharmacovigilance/"}]}, {"iso-a2":"IT",value:1975,category:"Full Member", links:[{name:"Agenzia Italiana del Farmaco",link:"https://www.aifa.gov.it/en/web/guest/farmacovigilanza1"}]}, {"iso-a2":"JE",value:1968,category:"Full Member", links:[{name:"Medicines and Healthcare products Regulatory Agency",link:"http://www.mhra.gov.uk"}]}, {"iso-a2":"JM",value:2012,category:"Full Member", links:[{name:"Pharmwatch Jamaica",link:"http://www.moh.gov.jm"}]}, {"iso-a2":"JO",value:2002,category:"Full Member", links:[{name:"Jordan Food and Drug Administration",link:"http://www.jfda.jo"}]}, {"iso-a2":"JP",value:1972,category:"Full Member", links:[{name:"Pharmaceuticals and Medical Devices Agency",link:"http://www.pmda.go.jp/english/index.html"}]}, {"iso-a2":"KE",value:2010,category:"Full Member", links:[{name:"Pharmacy and Poisons Board",link:"https://web.pharmacyboardkenya.org"}]}, {"iso-a2":"KG",value:2003,category:"Full Member", links:[{name:"Department of Drug Provision & Medical Equipment",link:"http://pharm.kg/ru/farmakonadzor/ "}]}, {"iso-a2":"KH",value:2012,category:"Full Member", links:[{name:"Cambodian Pharmacovigilance Center",link:"http://www.ddfcambodia.com"}]}, {"iso-a2":"KM",value:2023,category:"Associate Member", links:[]}, {"iso-a2":"KN",value:2008,category:"Associate Member", links:[{name:"Ministry of Health, St. Kitts and Nevis",link:"http://www.paho.org"}]}, {"iso-a2":"KR",value:1992,category:"Full Member", links:[{name:"Ministry of Food and Drug Safety",link:"http://www.mfds.go.kr/eng/index.do"}]}, {"iso-a2":"KW",value:2021,category:"Full Member", links:[]}, {"iso-a2":"KY",value:1968,category:"Full Member", links:[{name:"Medicines and Healthcare products Regulatory Agency",link:"http://www.mhra.gov.uk"}]}, {"iso-a2":"KZ",value:2008,category:"Full Member", links:[{name:"National Center for Expertise of medicines, medical devices and medical equipment - NCEMMD",link:"http://www.ndda.kz "}]}, {"iso-a2":"LA",value:2015,category:"Full Member", links:[{name:"Food and Drug Department, Ministry of Health",link:"http://www.fdd.gov.la"}]}, {"iso-a2":"LB",value:2021,category:"Full Member", links:[{name:"Ministry of Public Health",link:"https://www.moph.gov.lb/en/Pages/4/44742/pharmacovigilance-system-lebanon"}]}, {"iso-a2":"LC",value:2008,category:"Associate Member", links:[{name:"OECS - Pharmaceutical Procurement Service",link:"http://www.oecs.org/"},{name:"Ministry of Health, St Lucia",link:"http://www.paho.org"}]}, {"iso-a2":"LK",value:2000,category:"Full Member", links:[{name:"National Medicines Regulatory Authority",link:"http://nmra.gov.lk/index.php?lang=en"}]}, {"iso-a2":"LR",value:2013,category:"Full Member", links:[{name:"Liberia Medicines and Health Products Regulatory Authority",link:"https://www.lmhra.gov.lr/new/index.php"}]}, {"iso-a2":"LS",value:2024,category:"Full Member", links:[{name:"Ministry of Health Pharmacovigilance Programme",link:"http://health.gov.ls/"}]}, {"iso-a2":"LT",value:2005,category:"Full Member", links:[{name:"State Medicines Control Agency",link:"http://www.vvkt.lt/Pharmacovigilance"}]}, {"iso-a2":"LU",value:2020,category:"Full Member", links:[{name:"Division of Pharmacy and Medicines of the National Health Directorate",link:"https://guichet.public.lu/en/entreprises/sectoriel/sante/medecins/notification-effets-indesirables-medicaments.html"}]}, {"iso-a2":"LV",value:2002,category:"Full Member", links:[{name:"State Agency of Medicines of Latvia",link:"https://www.zva.gov.lv//?id=420&sa=420&top=386"}]}, {"iso-a2":"LY",value:2021,category:"Full Member", links:[{name:"Ministry of Health",link:"http://www.health.gov.ly/"}]}, {"iso-a2":"MA",value:1992,category:"Full Member", links:[{name:"Centre Anti Poison et de Pharmacovigilance",link:"https://www.capm-sante.ma/pv-pharmacovigilance"}]}, {"iso-a2":"MD",value:2003,category:"Full Member", links:[{name:"Medicines Agency",link:"http://amed.md/en/content/pharmacovigilance "}]}, {"iso-a2":"ME",value:2009,category:"Full Member", links:[{name:"Institute for Medicines and Medical Devices of Montenegro",link:"https://www.gov.me/en/government-of-montenegro/health"}]}, {"iso-a2":"MF",value:1986,category:"Full Member", links:[{name:"Agence nationale de sécurité du médicament et des produits de santé (ANSM)",link:"http://ansm.sante.fr"}]}, {"iso-a2":"MG",value:2009,category:"Full Member", links:[{name:"Agence du Médicament de Madagascar",link:"http://www.sante.gov.mg"}]}, {"iso-a2":"MK",value:2000,category:"Full Member", links:[{name:"North Macedonian Agency for medicines and medical devices",link:"https://malmed.gov.mk/"}]}, {"iso-a2":"ML",value:2011,category:"Full Member", links:[{name:"Centre National de Pharmacovigilance, Mali",link:""}]}, {"iso-a2":"MM",value:2018,category:"Associate Member", links:[{name:"Department of Food and Drug Administration, Ministry of Health and Sports",link:"http://www.fdamyanmar.gov.mm/"}]}, {"iso-a2":"MN",value:2021,category:"Full Member", links:[{name:"Medicine and Medical Device Regulatory Agency",link:"http://www.mmra.gov.mn"}]}, {"iso-a2":"MP",value:1968,category:"Full Member", links:[{name:"US FDA, Center for Biologics Evaluation and Research",link:"http://www.fda.gov/cber"},{name:" US FDA, Center for Drug Evaluation and Research",link:"http://www.fda.gov/cder"}]}, {"iso-a2":"MQ",value:1986,category:"Full Member", links:[{name:"Agence nationale de sécurité du médicament et des produits de santé (ANSM)",link:"http://ansm.sante.fr"}]}, {"iso-a2":"MR",value:2023,category:"Full Member", links:[{name:"Ministry of Health",link:"https://www.sante.gov.mr/?lang=fr"}]}, {"iso-a2":"MS",value:2008,category:"Associate Member", links:[{name:"Glendon Hospital Pharmacy",link:"http://www.paho.org"}],displayName:"Montserrat"}, {"iso-a2":"MT",value:2004,category:"Full Member", links:[{name:"Malta Medicines Authority",link:"http://www.medicinesauthority.gov.mt"}]}, {"iso-a2":"MU",value:2014,category:"Full Member", links:[{name:"National PV centre of Mauritius",link:""}]}, {"iso-a2":"MV",value:2016,category:"Full Member", links:[{name:"Maldives Food and Drug Authority",link:"https://health.gov.mv/en"}]}, {"iso-a2":"MW",value:2019,category:"Full Member", links:[{name:"Pharmacy, Medicines and Poisons Board",link:"http://www.health.gov.mw "}]}, {"iso-a2":"MX",value:1999,category:"Full Member", links:[{name:"Federal Commission for the Protection against Sanitary Risk",link:"https://www.gob.mx/cofepris"}]}, {"iso-a2":"MY",value:1990,category:"Full Member", links:[{name:"National Pharmaceutical Control Bureau",link:"https://www.npra.gov.my/index.php/en/pharmacovigilance-main-page.html"}]}, {"iso-a2":"MZ",value:2005,category:"Full Member", links:[{name:"Pharmaceutical Department",link:"http://www.misau.gov.mz/index.php"}]}, {"iso-a2":"NA",value:2008,category:"Full Member", links:[{name:"Namibia Medicines Regulatory Council",link:"https://nmrc.gov.na/"}]}, {"iso-a2":"NC",value:1986,category:"Full Member", links:[{name:"Agence nationale de sécurité du médicament et des produits de santé (ANSM)",link:"http://ansm.sante.fr"}]}, {"iso-a2":"NE",value:2012,category:"Full Member", links:[{name:"Direction de la Pharmacie, des Laboratoires et de la Médecine Traditionelle",link:"https://www.sante.gouvne.org/"}]}, {"iso-a2":"NF",value:1968,category:"Full Member", links:[{name:"Therapeutic Goods Administration",link:"http://www.tga.gov.au"}]}, {"iso-a2":"NG",value:2004,category:"Full Member", links:[{name:"National Agency for Food and Drug Administration and Control",link:"http://www.nafdac.gov.ng/index.php/about-nafdac/faqs/pharmacovigilance"}]}, {"iso-a2":"NI",value:2020,category:"Full Member", links:[{name:"Ministerio de Salud de Nicaragua",link:"http://www.minsa.gob.ni/"}]}, {"iso-a2":"NL",value:1968,category:"Full Member", links:[{name:"Netherlands Pharmacovigilance Centre Lareb",link:"http://www.lareb.nl/?lang=en-GB"}]}, {"iso-a2":"NO",value:1971,category:"Full Member", links:[{name:"Norwegian Medicines Agency",link:"https://legemiddelverket.no/English"}]}, {"iso-a2":"NP",value:2006,category:"Full Member", links:[{name:"Department of Drug Administration",link:"http://www.dda.gov.np"}]}, {"iso-a2":"NU",value:1968,category:"Full Member", links:[{name:"New Zealand Pharmacovigilance Centre",link:"http://www.otago.ac.nz/carm"}]}, {"iso-a2":"NZ",value:1968,category:"Full Member", links:[{name:"New Zealand Pharmacovigilance Centre",link:"http://www.otago.ac.nz/carm"}]}, {"iso-a2":"OM",value:1995,category:"Full Member", links:[{name:"Directorate General Pharmaceutical Affairs and Drug Control",link:"https://www.moh.gov.om/en_US/web/dgpadc"}]}, {"iso-a2":"PA",value:2005,category:"Full Member", links:[{name:"Centro Nacional de Farmacovigilancia",link:"http://www.minsa.gob.pa/informacion-salud/centro-nacional-de-farmacovigilancia"}]}, {"iso-a2":"PE",value:2002,category:"Full Member", links:[{name:"Direccion General de Medicamentos, Insumos y Drogas",link:"https://www.digemid.minsa.gob.pe/webDigemid/farmacovigilancia-y-tecnovigilancia/"}]}, {"iso-a2":"PF",value:1986,category:"Full Member", links:[{name:"Agence nationale de sécurité du médicament et des produits de santé (ANSM)",link:"http://ansm.sante.fr"}]}, {"iso-a2":"PG",value:2018,category:"Full Member", links:[{name:"Papua New Guinea Drug Information and Pharmacovigilance Unit",link:"http://www.health.gov.pg"}]}, {"iso-a2":"PH",value:1995,category:"Full Member", links:[{name:"Food and Drug Administration",link:"http://www.fda.gov.ph"}]}, {"iso-a2":"PK",value:2018,category:"Full Member", links:[{name:"Drug Regulatory Authority of Pakistan",link:"http://www.dra.gov.pk/"}]}, {"iso-a2":"PL",value:1972,category:"Full Member", links:[{name:"Office for Registration of Medicinal Products, URPL",link:"http://www.urpl.gov.pl/en"}]}, {"iso-a2":"PM",value:1986,category:"Full Member", links:[{name:"Agence nationale de sécurité du médicament et des produits de santé (ANSM)",link:"http://ansm.sante.fr"}]}, {"iso-a2":"PN",value:1968,category:"Full Member", links:[{name:"Medicines and Healthcare products Regulatory Agency",link:"http://www.mhra.gov.uk"}]}, {"iso-a2":"PR",value:1968,category:"Full Member", links:[{name:"US FDA, Center for Biologics Evaluation and Research",link:"http://www.fda.gov/cber"},{name:" US FDA, Center for Drug Evaluation and Research",link:"http://www.fda.gov/cder"}]}, {"iso-a2":"PT",value:1993,category:"Full Member", links:[{name:"INFARMED",link:"http://www.infarmed.pt/web/infarmed/entidades/medicamentos-uso-humano/farmacovigilancia"}]}, {"iso-a2":"PY",value:2018,category:"Full Member", links:[{name:"Dirección Nacional de Vigilancia Sanitaria",link:"https://www.mspbs.gov.py/dnvs"}]}, {"iso-a2":"QA",value:2013,category:"Associate Member", links:[{name:"Supreme Council of Health",link:"https://www.moph.gov.qa/home-en"}]}, {"iso-a2":"RE",value:1986,category:"Full Member", links:[{name:"Agence nationale de sécurité du médicament et des produits de santé (ANSM)",link:"http://ansm.sante.fr"}]}, {"iso-a2":"RO",value:1976,category:"Full Member", links:[{name:"National Agency for Medicines and Medical Devices",link:"https://www.anm.ro/en/"}]}, {"iso-a2":"RU",value:1998,category:"Full Member", links:[{name:"Federal Service on Surveillance in Healthcare and Soc.Dev",link:"http://www.roszdravnadzor.ru/drugs/monitpringlp "}]}, {"iso-a2":"RS",value:2000,category:"Full Member", links:[{name:"Medicines and Medical Devices Agency of Serbia",link:"http://www.alims.gov.rs"}]}, {"iso-a2":"RW",value:2013,category:"Full Member", links:[{name:"Pharmacy Task Force, Ministry of Health",link:"http://www.moh.gov.rw"}]}, {"iso-a2":"SA",value:2009,category:"Full Member", links:[{name:"Saudi Food and Drug Authority",link:"https://www.sfda.gov.sa/en"}]}, {"iso-a2":"SD",value:2008,category:"Full Member", links:[{name:"National Medicines and Poisons Board",link:"http://www.nmpb.gov.sd/"}]}, {"iso-a2":"SE",value:1968,category:"Full Member", links:[{name:"Medical Products Agency",link:"https://lakemedelsverket.se/english/"}]}, {"iso-a2":"SG",value:1993,category:"Full Member", links:[{name:"Health Sciences Authority",link:"http://www.hsa.gov.sg"}]}, {"iso-a2":"SH",value:1968,category:"Full Member", links:[{name:"Medicines and Healthcare products Regulatory Agency",link:"http://www.mhra.gov.uk"}]}, {"iso-a2":"SI",value:2010,category:"Full Member", links:[{name:"Agency for medicinal products and medical devices",link:"http://www.jazmp.si/en/"}]}, {"iso-a2":"SJ",value:1971,category:"Full Member", links:[{name:"Norwegian Medicines Agency",link:"https://legemiddelverket.no/English"}]}, {"iso-a2":"SK",value:1993,category:"Full Member", links:[{name:"State Institute for Drug Control, Slovakia",link:"http://www.sukl.sk/en/drug-safety/scope-of-activities?page_id=4020"}]}, {"iso-a2":"SL",value:2008,category:"Full Member", links:[{name:"Pharmacy Board of Sierra Leone",link:"https://www.pharmacyboard.gov.sl"}]}, {"iso-a2":"SN",value:2009,category:"Full Member", links:[{name:"Direction de la Pharmacie et des Laboratoires",link:"http://www.sante.gouv.sn"}]}, {"iso-a2":"SO",value:2024,category:"Associate Member",links:[{name:"Ministry of Health and Human Services"}]}, {"iso-a2":"SR",value:2007,category:"Full Member", links:[{name:"Office of Pharmacy Policy",link:""}]}, {"iso-a2":"SS",value:2024,category:"Full Member",links:[{name:"Ministry of Health",link:"https://moh.gov.ss/"}]}, {"iso-a2":"ST",value:2023,category:"Associate Member",links:[{name:"",link:""}]}, {"iso-a2":"SV",value:2017,category:"Full Member", links:[{name:"Ministerio de Salud",link:"http://www.salud.gob.sv"}]}, {"iso-a2":"SX",value:1968,category:"Full Member", links:[{name:"Netherlands Pharmacovigilance Centre Lareb",link:"http://www.lareb.nl/?lang=en-GB"}]}, {"iso-a2":"SY",value:2018,category:"Full Member", links:[{name:"Syrian Ministry of Health",link:"http://www.moh.gov.sy"}]}, {"iso-a2":"SZ",value:2015,category:"Full Member", links:[{name:"Eswatini Pharmacovigilance Centre - Central Medical Stores",link:"http://www.gov.sz/index.php?option=com_content&view=article&id=267&Itemid=403"}]}, {"iso-a2":"TC",value:1968,category:"Full Member", links:[{name:"Medicines and Healthcare products Regulatory Agency",link:"http://www.mhra.gov.uk"}]}, {"iso-a2":"TD",value:2018,category:"Full Member", links:[{name:"Bureau de Pharmacovigilance",link:""}]}, {"iso-a2":"TH",value:1984,category:"Full Member", links:[{name:"Thai Food and Drug Administration",link:"https://en.fda.moph.go.th/"}]}, {"iso-a2":"TG",value:2007,category:"Full Member", links:[{name:"Direction de la Pharmacie, du Médicament et des Laboratoires",link:"https://www.dpmltogo.org/"}]}, {"iso-a2":"TJ",value:2023,category:"Full Member", links:[{name:"Office of National Supervision for Pharmaceutical Activities",link:"http://www.pharmnadzor.tj/index.html"}]}, {"iso-a2":"TK",value:1968,category:"Full Member", links:[{name:"New Zealand Pharmacovigilance Centre",link:"http://www.otago.ac.nz/carm"}]}, {"iso-a2":"TL",value:2019,category:"Associate Member", links:[{name:"Ministry of Health",link:"http://moh.gov.tl/"}]}, {"iso-a2":"TN",value:1993,category:"Full Member", links:[{name:"Centre National de Pharmacovigilance, Tunisia",link:"http://www.pharmacovigilance.rns.tn/"}]}, {"iso-a2":"TR",value:1987,category:"Full Member", links:[{name:"Turkish Pharmacovigilance Center",link:"http://www.titck.gov.tr"}]}, {"iso-a2":"TZ",value:1993,category:"Full Member", links:[{name:"Tanzania Medicines and Medical Devices Authority",link:"https://www.tmda.go.tz/"},{name:" Zanzibar Food and Drugs Board",link:"http://www.zfdb.go.tz"}]}, {"iso-a2":"UA",value:2002,category:"Full Member", links:[{name:"State Expert Center",link:"http://www.dec.gov.ua/index.php/ua/farmakonaglyad "}]}, {"iso-a2":"UG",value:2007,category:"Full Member", links:[{name:"National Drug Authority",link:"http://www.nda.or.ug"}]}, {"iso-a2":"UM",value:1968,category:"Full Member", links:[{name:"US FDA, Center for Biologics Evaluation and Research",link:"http://www.fda.gov/cber"},{name:" US FDA, Center for Drug Evaluation and Research",link:"http://www.fda.gov/cder"}]}, {"iso-a2":"US",value:1968,category:"Full Member", links:[{name:"US FDA, Center for Biologics Evaluation and Research",link:"http://www.fda.gov/cber"},{name:" US FDA, Center for Drug Evaluation and Research",link:"http://www.fda.gov/cder"}]}, {"iso-a2":"UY",value:2001,category:"Full Member", links:[{name:"Department of Pharmaceuticals",link:"http://www.msp.gub.uy"}]}, {"iso-a2":"UZ",value:2006,category:"Full Member", links:[{name:"Pharmacological Committee of HDDMEC",link:"http://uzpharm-control.uz/"}]}, {"iso-a2":"VC",value:2020,category:"Full Member", links:[{name:"SVG Pharmacovigilance & Drug Information Centre",link:"https://www.paho.org/en/saint-vincent-and-grenadines"}]}, {"iso-a2":"VE",value:1995,category:"Full Member", links:[{name:"Instituto Nacional de Higiene, Rafael Rangel",link:"http://www.inhrr.gob.ve/"}]}, {"iso-a2":"VG",value:2008,category:"Associate Member", links:[{name:"",link:""}],displayName:"British Virgin Islands"}, {"iso-a2":"VI",value:1968,category:"Full Member", links:[{name:"US FDA, Center for Biologics Evaluation and Research",link:"http://www.fda.gov/cber"},{name:"US FDA, Center for Drug Evaluation and Research",link:"http://www.fda.gov/cder"}]}, {"iso-a2":"VN",value:1999,category:"Full Member", links:[{name:"National Centre of Drug Information & Adverse Drug Reactions",link:"http://canhgiacduoc.org.vn/en.aspx"}]}, {"iso-a2":"WF",value:1986,category:"Full Member", links:[{name:"Agence nationale de sécurité du médicament et des produits de santé (ANSM)",link:"http://ansm.sante.fr"}]}, {"iso-a2":"YE",value:2022,category:"Full Member", links:[{name:"Yemeni National Pharmacovigilance Centre",link:"http://www.sbd-ye.org/"}]}, {"iso-a2":"YT",value:1986,category:"Full Member", links:[{name:"Agence nationale de sécurité du médicament et des produits de santé (ANSM)",link:"http://ansm.sante.fr"}]}, {"iso-a2":"ZA",value:1992,category:"Full Member", links:[{name:"Medicines Regulatory Authority",link:"https://www.sahpra.org.za/"}]}, {"iso-a2":"ZM",value:2010,category:"Full Member", links:[{name:"Zambia Medicines Regulatory Authority",link:"http://www.zamra.co.zm"}]}, {"iso-a2":"ZW",value:1998,category:"Full Member", links:[{name:"Medicines Control Authority of Zimbabwe",link:"https://www.mcaz.co.zw/"}]}],joinBy: 'iso-a2',name: 'Member status',mapData: Highcharts.maps['custom/world-palestine']}] { colorAxis: { min: 1979, minColor: '#f0e7ef', maxColor: '#77216c' }, tooltip: { formatter: function () { var tooltip = '' + this.point.name + '' + this.point.category + ' since ' + this.point.value + ''; var infoItems = this.point["links"]; if (infoItems && infoItems.length) { $.each(infoItems, function (index, item) { if(item.link) { tooltip += '' + item.name + ''; } else { tooltip += item.name + ''; } }) } return tooltip; }, useHTML: true }} The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization or Uppsala Monitoring Centre concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. Follow us on social media: © Uppsala Monitoring Centre · Privacy Policy · Cookie Policy · Contact us · Status

1727488312

https://who-umc.org

0.0046238899230957

Advancing medicines safety together